In today's competitive medical marketplace, often the difference between success and failure is having the right information at the right time - the right information BEFORE you finalize market strategy, select a corporate partner, initiate product development, begin a clinical trial or prepare an FDA submission.

BioCom is building pathways to the next generation of medicine based on rational insights into the fundamental mechanisms of disease. We are a leader in the field of genomics - the identification and functional characterization of genes. The Company's commercial gene discovery strategy is to identify and characterize human genes associated with major diseases and elucidate bacterial and fungal genes responsible for many serious infectious diseases.

The pharmaceutical industry has benefited for decades from developing drugs which address only the symptoms of disease. The traditional approach is rapidly becoming obsolete. Modern science, fueled by genomic information, is allowing deeper insights into fundamental causes of disease. BioCom is among the leaders of this pharmaceutical discovery revolution.

BioCom is addressing major unmet medical needs with enormous market potential. The genomic information generated by BioCom will allow the Company, together with its corporate partners, to develop a new generation of pharmaceuticals and medical services.